Pharmacological characteristics of leukotriene antagonists
Nicosia, S.
Monaldi Archives for Chest Disease 51(6): 556
1996
ISSN/ISBN: 1122-0643 PMID: 9046173 Document Number: 465939
Document emailed within 1 workday
Related Documents
Costantino, S. 2002: Are leukotriene antagonists effective in bronchial asthma? La Clinica Terapeutica 153(5): 303-304Konno, R.; Fujiwara, H.; Suzuki, M. 2004: Effectiveness of leukotriene receptor antagonists for dysmenorrhea of endometriosis Family Medicine 36(1): 8-9
Bjermer, L.; Diamant, Z. 2002: The use of leukotriene receptor antagonists (LTRAs) as complementary therapy in asthma Monaldi Archives for Chest Disease 57(1): 76-83
Czarnecka-Operacz, M.; Jenerowicz, D. 2003: Leukotriene receptor antagonists--possible therapeutic option in the treatment of atopic dermatitis Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 14(79): 86-88
Kupryś, I.; Kuna, P. 2000: The role of leukotrienes and the effect of leukotriene receptor antagonists in allergic rhinitis Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 9(52): 717-720
Yonekura, S.; Okamoto, Y.; Okubo, K.; Okawa, T.; Gotoh, M.; Suzuki, H.; Kakuma, T.; Horiguchi, S.; Hanazawa, T.; Konno, A.; Okuda, M. 2009: Beneficial effects of leukotriene receptor antagonists in the prevention of cedar pollinosis in a community setting Journal of Investigational Allergology and Clinical Immunology 19(3): 195-203
Tashkin, D.P. 2001: The importance of control in asthma management: do leukotriene receptor antagonists meet patient and physician needs? Allergy and Asthma Proceedings 22(5): 311-319
Ledda, F. 1978: Pharmacological assumptions in the use of calcium antagonists Bollettino Della Societa Italiana di Cardiologia 1978(1 Suppl): 10-13
Scriabine, A.; Kazda, S. 1989: Pharmacological basis for use of calcium antagonists in hypertension Magnesium 8(5-6): 253-265
Hullot, P.; Poudrel, J.M.; Muller, A.; Escale, R.; Rossi, J.C.; Girard, J.P.; Bonne, C. 1997: Synthesis and biochemical/pharmacological profile of the novel leukotriene B4 receptor antagonist sodium (1S*, 3S*)-1-hydroxy-3-[(3 R*S*,E)-3-hydroxy-7-phenyl-1-hepten-1-yl]-1-cyclohexane acetate Arzneimittel-Forschung 47(1): 51-58
Thien, F.C.; Hallsworth, M.P.; Soh, C.; Lee, T.H. 1993: Effects of exogenous eicosapentaenoic acid on generation of leukotriene C4 and leukotriene C5 by calcium ionophore-activated human eosinophils in vitro Journal of Immunology 150(8 Part 1): 3546-3552
Makovec, F.; Bani, M.; Cereda, R.; Chisté, R.; Pacini, M.A.; Revel, L.; Rovati, L.A.; Rovati, L.C.; Setnikar, I. 1987: Pharmacological properties of lorglumide as a member of a new class of cholecystokinin antagonists Arzneimittel-Forschung 37(11): 1265-1268
Mong, S.; Wu, H.L.; Miller, J.; Hall, R.F.; Gleason, J.G.; Crooke, S.T. 1987: SKF 104353, a high affinity antagonist for human and guinea pig lung leukotriene D4 receptor, blocked phosphatidylinositol metabolism and thromboxane synthesis induced by leukotriene D4 Molecular Pharmacology 32(1): 223-229
Levi-Schaffer, F.; Dayton, E.T.; Austen, K.F.; Hein, A.; Caulfield, J.P.; Gravallese, P.M.; Liu, F.T.; Stevens, R.L. 1987: Mouse bone marrow-derived mast cells cocultured with fibroblasts. Morphology and stimulation-induced release of histamine, leukotriene B4, leukotriene C4, and prostaglandin D2 Journal of Immunology 139(10): 3431-3441
Luĭk, A.I.; Prokopenko, V.V.; Tanchuk, V.I.; Kholodovich, V.V.; Semeniuta, I.V. 1999: Common properties of pharmacological agonists and antagonists of surface membrane receptors Voprosy Meditsinskoi Khimii 45(6): 514-524
Ivey, K.J. 1974: Control of gastric acid secretion by histamine H2-receptor antagonists; a pharmacological dream come true Australian and New Zealand Journal of Medicine 4(5): 521-524
Prado de Carvalho, L.; Venault, P.; Cavalheiro, E.; Kaijima, M.; Valin, A.; Dodd, R.H.; Potier, P.; Rossier, J.; Chapouthier, G. 1983: Distinct behavioral and pharmacological effects of two benzodiazepine antagonists: Ro 15-1788 and methyl beta-carboline Advances in Biochemical Psychopharmacology 38: 175-187
Piascik, M.F.; Rahwan, R.G.; Witiak, D.T. 1978: Pharmacological evaluation of new calcium antagonists: 2-substituted 3-dimethylamino-5,6-methylenedioxyindenes. Effects on adrenomedullary catecholamine secretion Journal of Pharmacology and Experimental Therapeutics 205(1): 155-163
Ballerini, P.; Di Iorio, P.; Ciccarelli, R.; Caciagli, F.; Poli, A.; Beraudi, A.; Buccella, S.; D'Alimonte, I.; D'Auro, M.; Nargi, E.; Patricelli, P.; Visini, D.; Traversa, U. 2005: P2Y1 and cysteinyl leukotriene receptors mediate purine and cysteinyl leukotriene co-release in primary cultures of rat microglia International Journal of Immunopathology and Pharmacology 18(2): 255-268
MacGlashan, D.W.; Peters, S.P.; Warner, J.; Lichtenstein, L.M. 1986: Characteristics of human basophil sulfidopeptide leukotriene release: releasability defined as the ability of the basophil to respond to dimeric cross-links Journal of Immunology 136(6): 2231-2239